pfizer glp-1 Readout Newsletter: Abeona, Pfizer, Regeneron, AstraZeneca How Pfizer ended up passing
Description
The FDA has approved three GLP-1 receptor agonist drugs for weight loss
What is it and what are the pros and cons?
The incretin hormone glucagon-like peptide 1 (GLP-1) has been implicated in the gutrenal axis and incretin-based therapies might reduce the burden of diabetic kidney disease
Clinical Significance: The 2025 updates reaffirm that while HbA1c remains central, a one-number-fits-all strategy is outdated
Learn how they work, who theyre for, and the truth about microdosing.
